Leading the way for pediatric behavioral health.
We are developing digital diagnostics and therapeutics to enable earlier treatment of behavioral health conditions.
Behavioral Health Platform for Earlier Detection, Diagnosis, and Care
Our proprietary machine-learning platform provides for a continuum of care from identification and diagnostic aid to digital therapeutics, to improve lifelong outcomes for children.
Providers
Take action on concerns to identify and treat behavioral health conditions earlier with prescription medical devices that easily integrate into your workflow.
Employers
Empower employees to positively impact the behavioral health and unique developmental growth of their children.
FDA Breakthrough designation products
Cognoa has received Breakthrough Device Designation from the FDA for both its lead products, a digital diagnostic and therapeutic for autism.
Early Intervention Lasts a Lifetime
When children have access to treatments during early childhood, they have the best opportunity to reach their full potential in life. When they don’t, treatments are likely to be less impactful, children and families suffer, and it’s more costly for our healthcare system and communities.
